BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qiu LW, Liu YF, Cao XQ, Wang Y, Cui XH, Ye X, Huang SW, Xie HJ, Zhang HJ. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment. World J Gastroenterol 2020; 26(18): 2126-2137 [PMID: 32476780 DOI: 10.3748/wjg.v26.i18.2126] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdelraouf EM, Hussein RRS, Shaaban AH, El-Sherief HAM, Embaby AS, Abd El-Aleem SA. Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression. Life Sci 2022;308:120967. [PMID: 36116530 DOI: 10.1016/j.lfs.2022.120967] [Reference Citation Analysis]
2 Barreno-rocha SG, Guzmán-silahua S, Rodríguez-dávila S, Gavilanez-chávez GE, Cardona-muñoz EG, Riebeling-navarro C, Rubio-jurado B, Nava-zavala AH. Antiphospholipid Antibodies and Lipids in Hematological Malignancies. IJMS 2022;23:4151. [DOI: 10.3390/ijms23084151] [Reference Citation Analysis]
3 Li C, Zhao Z, Zhao S. Annexin A2 promotes development of retinal neovascularization through PI3K/ AKT signaling pathway. Curr Eye Res 2021;:1-11. [PMID: 34894941 DOI: 10.1080/02713683.2021.2018467] [Reference Citation Analysis]
4 Zhang H, Liu Y, Cao X, Wang W, Cui X, Yang X, Wang Y, Shi J. Nrf2 Promotes Inflammation in Early Myocardial Ischemia-Reperfusion via Recruitment and Activation of Macrophages. Front Immunol 2021;12:763760. [DOI: 10.3389/fimmu.2021.763760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Ma K, Chen X, Liu W, Yang Y, Chen S, Sun J, Ma C, Wang T, Yang J. ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression. Sci Rep 2021;11:20839. [PMID: 34675316 DOI: 10.1038/s41598-021-00366-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
6 Rocha MR, Morgado-Diaz JA. Epithelial-Mesenchymal Transition in colorectal cancer: Annexin A2 is caught in the crosshairs. J Cell Mol Med 2021;25:10774-7. [PMID: 34626069 DOI: 10.1111/jcmm.16962] [Reference Citation Analysis]
7 Huang SW, Chen YC, Lin YH, Yeh CT. Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma. J Clin Med 2021;10:4158. [PMID: 34575275 DOI: 10.3390/jcm10184158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu W, Jia G, Chen L, Liu H, Xia S. Analysis of the Expression and Prognostic Value of Annexin Family Proteins in Bladder Cancer. Front Genet 2021;12:731625. [PMID: 34484309 DOI: 10.3389/fgene.2021.731625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Sun T, Zhang J. ETV4 mediates the wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression. J Biochem 2021:mvab088. [PMID: 34347084 DOI: 10.1093/jb/mvab088] [Reference Citation Analysis]
10 Li J, Yu Z, Zhu Q, Tao C, Xu Q. hsa_circ_102559 Acts as the Sponge of miR-130a-5p to Promote Hepatocellular Carcinoma Progression Through Regulation of ANXA2. Cell Transplant 2020;29:963689720968748. [PMID: 33121269 DOI: 10.1177/0963689720968748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lindblad KE, Ruiz de Galarreta M, Lujambio A. Tumor-Intrinsic Mechanisms Regulating Immune Exclusion in Liver Cancers. Front Immunol 2021;12:642958. [PMID: 33981303 DOI: 10.3389/fimmu.2021.642958] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
12 Brocco D, Lanuti P, Pieragostino D, Cufaro MC, Simeone P, Bologna G, Di Marino P, De Tursi M, Grassadonia A, Irtelli L, De Lellis L, Veschi S, Florio R, Federici L, Marchisio M, Miscia S, Cama A, Tinari N, Del Boccio P. Phenotypic and Proteomic Analysis Identifies Hallmarks of Blood Circulating Extracellular Vesicles in NSCLC Responders to Immune Checkpoint Inhibitors. Cancers (Basel) 2021;13:585. [PMID: 33546102 DOI: 10.3390/cancers13040585] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
13 Han W, Yu F, Guan W. Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers. Biomed Pharmacother 2020;130:110632. [PMID: 34321169 DOI: 10.1016/j.biopha.2020.110632] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]